Integrated Clinical and Omics information Registry in Pulmonary Hypertensio
Not Applicable
Recruiting
- Conditions
- Pulmonary arterial hypertension
- Registration Number
- JPRN-UMIN000052692
- Lead Sponsor
- ational Hospital Organization Okayama Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 1000
Inclusion Criteria
Not provided
Exclusion Criteria
Patients judged to be inappropriate as a candidate by the investigators.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1) Deaths (all cause or disease related)) 2) EQ-5D-5L Survey 3) Treatment details 4) Clinical severity including hemodynamics
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie pulmonary arterial hypertension progression in the RADDAR-J registry?
How does the RADDAR-J registry compare standard-of-care treatments for pulmonary arterial hypertension outcomes?
What biomarkers are being evaluated for patient selection in the RADDAR-J pulmonary hypertension registry?
What adverse event profiles are associated with pulmonary arterial hypertension therapies in the RADDAR-J study?
What novel drug targets have emerged from omics data in the RADDAR-J pulmonary hypertension registry?